Association Between Exposure to Ambient Particulate Matter and Chronic Obstructive Pulmonary Disease: Results from a Cross-sectional Study in China
Overview
Authors
Affiliations
Objective: The association between exposure to ambient particles with a median aerodynamic diameter less than 10/2.5 µm (particulate matter, PM/) and COPD remains unclear. Our study objective was to examine the association between ambient PM/ concentrations and lung functions in adults.
Methods: A cross-sectional study was conducted in southern China. Seven clusters were randomly selected from four cities across Guangdong province. Residents aged ≥20 years in the participating clusters were randomly recruited; all eligible participants were examined with a standardised questionnaire and spirometry. COPD was defined as a post-bronchodilator FEV/FVC less than 70%. Atmosphere PM sampling was conducted across the clusters along with our survey.
Results: Of the subjects initially recruited, 84.4% (n=5993) were included for analysis. COPD prevalence and atmosphere PM concentration varied significantly among the seven clusters. COPD prevalence was significantly associated with elevated PM concentration levels: adjusted OR 2.416 (95% CI 1.417 to 4.118) for >35 and ≤75 µg/m and 2.530 (1.280 to 5.001) for >75 µg/m compared with the level of ≤35 µg/m for PM; adjusted OR 2.442 (95% CI 1.449 to 4.117) for >50 and ≤150 µg/m compared with the level of ≤50 µg/m for PM. A 10 µg/m increase in PM concentrations was associated with a 26 mL (95% CI -43 to -9) decrease in FEV, a 28 mL (-49 to -8) decrease in FVC and a 0.09% decrease (-0.170 to -0.010) in FEV/FVC ratio. The associations of COPD with PM were consistent with PM but slightly weaker.
Conclusions: Exposure to higher PM concentrations was strongly associated with increased COPD prevalence and declined respiratory function.
Trial Registration Number: ChiCTR-OO-14004264; Post-results.
Sana A, Kafando B, Meda N, Bouland C Pan Afr Med J. 2025; 49:88.
PMID: 40027090 PMC: 11871887. DOI: 10.11604/pamj.2024.49.88.43238.
Du J, Cui H, Zhao Y, Xue H, Chen J Osteoporos Int. 2024; 35(12):2215-2223.
PMID: 39307894 DOI: 10.1007/s00198-024-07249-4.
Wang C, Qi W, Yang T, Jiao L, Chen Q, Huang K EClinicalMedicine. 2024; 74:102597.
PMID: 39114273 PMC: 11305216. DOI: 10.1016/j.eclinm.2024.102597.
Deng Z, Wu F, Wan Q, Dai C, Lu L, Peng J BMJ Open Respir Res. 2024; 11(1).
PMID: 39032939 PMC: 11261676. DOI: 10.1136/bmjresp-2024-002320.
Xu J, Chen Y, Lu F, Chen L, Dong Z Toxics. 2024; 12(6).
PMID: 38922073 PMC: 11209456. DOI: 10.3390/toxics12060393.